1. Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 2002;21:167-178. PMID:
11857671.
2. Coyne KS, Sexton CC, Vats V, Thompson C, Kopp ZS, Milsom I. National community prevalence of overactive bladder in the United States stratified by sex and age. Urology 2011;77:1081-1087. PMID:
21256571.
3. Lee YS, Lee KS, Jung JH, Han DH, Oh SJ, Seo JT, et al. Prevalence of overactive bladder, urinary incontinence, and lower urinary tract symptoms: results of Korean EPIC study. World J Urol 2011;29:185-190. PMID:
19898824.
4. Matza LS, Thompson CL, Krasnow J, Brewster-Jordan J, Zyczynski T, Coyne KS. Test-retest reliability of four questionnaires for patients with overactive bladder: the overactive bladder questionnaire (OAB-q), patient perception of bladder condition (PPBC), urgency questionnaire (UQ), and the primary OAB symptom questionnaire (POSQ). Neurourol Urodyn 2005;24:215-225. PMID:
15747340.
5. Zinner N, Harnett M, Sabounjian L, Sandage B Jr, Dmochowski R, Staskin D. The overactive bladder-symptom composite score: a composite symptom score of toilet voids, urgency severity and urge urinary incontinence in patients with overactive bladder. J Urol 2005;173:1639-1643. PMID:
15821526.
6. Homma Y, Yoshida M, Seki N, Yokoyama O, Kakizaki H, Gotoh M, et al. Symptom assessment tool for overactive bladder syndrome--overactive bladder symptom score. Urology 2006;68:318-323. PMID:
16904444.
7. Tsujimura A, Takao T, Miyagawa Y, Yamamoto K, Fukuhara S, Nakayama J, et al. Urgency is an independent factor for sleep disturbance in men with obstructive sleep apnea. Urology 2010;76:967-970. PMID:
20381845.
8. Tanaka Y, Masumori N, Tsukamoto T. Urodynamic effects of solifenacin in untreated female patients with symptomatic overactive bladder. Int J Urol 2010;17:796-800. PMID:
20649825.
9. Watanabe M, Yamanishi T, Honda M, Sakakibara R, Uchiyama T, Yoshida K. Efficacy of extended-release tolterodine for the treatment of neurogenic detrusor overactivity and/or low-compliance bladder. Int J Urol 2010;17:931-936. PMID:
20969642.
10. Gotoh M, Yokoyama O, Nishizawa O. Japanese Propiverine Study Group. Propiverine hydrochloride in Japanese patients with overactive bladder: a randomized, double-blind, placebo-controlled trial. Int J Urol 2011;18:365-373. PMID:
21332825.
11. Homma Y, Kakizaki H, Yamaguchi O, Yamanishi T, Nishizawa O, Yokoyama O, et al. Assessment of overactive bladder symptoms: comparison of 3-day bladder diary and the overactive bladder symptoms score. Urology 2011;77:60-64. PMID:
20951412.
12. Yamaguchi O, Nishizawa O, Takeda M, Yokoyama O, Homma Y, Kakizaki H, et al. Clinical guidelines for overactive bladder. Int J Urol 2009;16:126-142. PMID:
19228224.
13. Homma Y, Yoshida M, Obara K, Seki N, Yamaguchi O. Development and validity of the Overactive Bladder Symptom Score (OABSS). Jpn J Urol 2005;96:182.
14. Oh SJ, Park HG, Paick SH, Park WH, Choo MS. Translation and linguistic validation of Korean version of the King's Health Questionnaire Instrument. Korean J Urol 2005;46:438-450.
15. Coyne KS, Sexton CC, Kopp ZS, Ebel-Bitoun C, Milsom I, Chapple C. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. BJU Int 2011 3 03;[Epub]. DOI:
10.1111/j.1464-410X.2010.10013.x.
16. Heidler S, Mert C, Wehrberger C, Temml C, Ponholzer A, Rauchenwald M, et al. Impact of overactive bladder symptoms on sexuality in both sexes. Urol Int 2010;85:443-446. PMID:
20962511.
17. Moon SJ, Kim YT, Lee TY, Moon H, Kim MJ, Kim SA, et al. The influence of an overactive bladder on falling: a study of females aged 40 and older in the community. Int Neurourol J 2011;15:41-47. PMID:
21468286.
18. Novara G, Galfano A, Secco S, DElia C, Cavalleri S, Ficarra V, et al. A systematic review and meta-analysis of randomized controlled trials with antimuscarinic drugs for overactive bladder. Eur Urol 2008;54:740-763. PMID:
18632201.
19. Chapple CR, Artibani W, Cardozo LD, Castro-Diaz D, Craggs M, Haab F, et al. The role of urinary urgency and its measurement in the overactive bladder symptom syndrome: current concepts and future prospects. BJU Int 2005;95:335-340. PMID:
15679789.
20. Homma Y, Gotoh M. Symptom severity and patient perceptions in overactive bladder: how are they related? BJU Int 2009;104:968-972. PMID:
19338560.
21. Oh SJ, Park HG, Lim SH, Hong SK, Kim SW, Kim HH, et al. Translation and linguistic validation of Korean version of the Incontinence quality of life(I-QoL) instrument. J Korean Continence Soc 2002;6:10-23.
22. Son HC, Jung YJ, Chang JS, Kim SH, Hong SK, Oh SJ, et al. Translation and linguistic validation of the Korean version of the pelvic pain and urgency/frequency patient symptom scale. Int Neurourol J 2010;14:112-121. PMID:
21120221.